Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of ...
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Developing a top-selling vaccine for Covid-19 drove Pfizer’s profits. At least for a while. But a few years on, the intense injection of cash that catapulted the 175-year-old drugmaker to one of the ...
Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...
In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board ...
(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...